InflaRx (IFRX) Preferred Shares (2016 - 2017)

InflaRx (IFRX) posted Preferred Shares of $67.5 million for Q3 2017, up 16.95% sequentially from $57.7 million in Q4 2016.

InflaRx (IFRX) Preferred Shares (2016 - 2017) Analysis & Trends

InflaRx has reported Preferred Shares for 2 years, with the latest figure at $67.5 million in Q3 2017.

Quarterly Preferred Shares changed N/A year-over-year to $67.5 million in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $67.5 million (changed N/A YoY) and the FY2016 annual result came in at $59.2 million, changed N/A from the prior year.
Preferred Shares climbed to $67.5 million in Q3 2017 per IFRX's latest filing, from $57.7 million in the prior quarter.
Over five years, Preferred Shares peaked at $67.5 million in Q3 2017 and troughed at $57.7 million in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	InflaRx	140.30 Mn	-43.96 Mn	2.74 Bn	-

Download Data

Date	Value
Sep 30, 2017	67.48 Mn
Dec 31, 2016	57.70 Mn